Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2013 Annual Report - PDF 2013 Annual Report
OSUR (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$6.44
Change (%) Stock is Down 0.03 (0.46%)
Volume752,900
Data as of 04/15/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
04/04/14OraSure Technologies' Debra Fraser-Howze Receives 2014 "Top Blacks in Healthcare" Award
OraSure Executive Recognized by Johns Hopkins Center for Health Disparities Solutions and BlackDoctor.org BETHLEHEM, Pa., April 4, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) is proud to announce that Debra Fraser-Howze, the Company's Senior Vice President of Government and External Affairs, received a 2014 "Top Blacks in Healthcare" Award from BlackDoctor.org in partnership with Johns Hopkins Center for Health Disparities Solutions. The award honors those who have out... 
Printer Friendly Version
02/26/14OraSure Technologies to Present at the Cowen & Company 34th Annual Health Care Conference
BETHLEHEM, Pa., Feb. 26, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Cowen & Co. 34th Annual Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak March 5, 2014, at approximately 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time). Interested investors can access the live w... 
Printer Friendly Version
02/24/14OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 24, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Florida. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak March 3, 2014, at approximately 8:40 am Eastern Time (5:40 am Pacific Time). Interested investors can access the live ... 
Printer Friendly Version
02/20/14OraSure Technologies to Present at the 2014 Citi Global Healthcare Conference
BETHLEHEM, Pa., Feb. 20, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2014 Citi Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak February 25, 2014, at approximately 1:50pm Eastern Time (10:50am Pacific Time). Interested investors can access the live webcast of the present... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/22/14
OraSure Technologies, Inc. Annual Shareholder Meeting
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet